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INTRODUCTION
The vertebrate eye, which is composed of neurogenic and non-
neurogenic structures, arises from a single progenitor pool in the
optic vesicle. The eye, therefore, provides a useful and accessible
model for studying potential interactions of signaling pathways in
the specification of distinct cell fates. At around embryonic day (E)
10.5 of mouse development, the optic vesicle receives signals from
the surface ectoderm telling it to invaginate, forming the bilayered
optic cup. The inner layer of the optic cup gives rise to the neural
retina (NR) and the outer layer becomes the retinal pigment
epithelium (RPE). The interface of these two domains is the
peripheral optic cup margin, which gives rise to the non-pigmented
ciliary body epithelium (CE) and the inner iris epithelium.
Progenitor cells at the boundary between prospective NR and CE
make a binary cell fate decision to become either neurogenic (NR)
or non-neurogenic (CE) (Beebe, 1986). The molecular and cellular
mechanisms regulating this cell fate decision are poorly
understood, in part because cells fated to become CE exhibit
pervasive expression of the retinal progenitor transcription factors
Rax, Chx10 (Vsx2 – Mouse Genome Informatics) and Pax6 (Cho
and Cepko, 2006; Fuhrmann et al., 2000; Furukawa et al., 1997;
Hodgkinson et al., 1993; Kubo and Nakagawa, 2008; Liu et al.,
2006; Liu et al., 2003; Pittack et al., 1997; Rowan and Cepko,
2004).
A number of cell-extrinsic signaling pathways have been
implicated in CE fate specification. One report showed that CE
markers are found at the edges of tissue that ectopically expresses
fibroblast growth factor (FGF), suggesting that the ciliary body is
specified in the optic vesicle where bone morphogenetic protein
(BMP) and FGF signals overlap (Dias da Silva et al., 2007). In
addition, studies in multiple species have shown canonical Wnt
signaling to be a potent regulator of peripheral eye structures (Cho
and Cepko, 2006; Liu, H. et al., 2007; Tomlinson, 2003). A role for
Wnt signaling in specifying CE fate in the mouse comes from the
observation that constitutive activation of -catenin in optic cup
progenitor cells results in ectopic expression of CE-specific genes
at the expense of NR-specific genes (Liu, H. et al., 2007).
However, these ectopic CE-like cells fail to express Pax6 and
Chx10, both of which are normally maintained in the prospective
CE of control eyes at early stages. In the adult, Pax6 is maintained
in the CE of the iris and ciliary body.
The reduction of Pax6 expression upon activated Wnt signaling
is surprising given that PAX6 is a positive regulator of peripheral
eyecup development (Davis-Silberman et al., 2005). A member of
the paired-box and homeobox-containing family of transcription
factors, PAX6 has been shown to be required for iris specification,
optic cup morphogenesis, lens formation and retinal neuronal
differentiation (Baumer et al., 2002; Davis-Silberman and Ashery-
Padan, 2008; Davis-Silberman et al., 2005; Grindley et al., 1997;
Marquardt et al., 2001; Philips et al., 2005; Smith et al., 2009; Xu
et al., 1999). These developmental processes require a critical
threshold of PAX6 as demonstrated by the fact that heterozygous
carriers of PAX6 deletions (Davis-Silberman et al., 2005; Hill et al.,
1991; Hogan et al., 1986; Ton et al., 1991) and transgenic mice
with increased levels of PAX6 (Ericson et al., 1997; Schedl et al.,
1996) display eye abnormalities (Favor et al., 2001; Hack et al.,
2004; Heins et al., 2002; Kim and Lauderdale, 2008; Manuel et al.,
2007). Humans with mutations in PAX6 exhibit aniridia (no iris)
and often have smaller ciliary bodies (reviewed by Hanson and Van
Heyningen, 1995; Hayashi et al., 2004; Okamoto et al., 2004;
Prosser and van Heyningen, 1998). Mice that are haploinsufficient
for Pax6 exhibit reduced size of the optic cup margin, implicating
a shift in the boundary between NR and CE (Davis-Silberman et
al., 2005).
Here, we test the hypothesis that there is an antagonistic
relationship between transcription factors that are restricted to the
prospective NR and those that, like PAX6, span the boundary
Development 138, 443-454 (2011) doi:10.1242/dev.055178
© 2011. Published by The Company of Biologists Ltd
1UNC Neuroscience Center, University of North Carolina at Chapel Hill, 27599 NC,
USA. 2UNC Genetics Curriculum, University of North Carolina at Chapel Hill, 27599
NC, USA. 3Department of Genetics, University of North Carolina at Chapel Hill,
27599 NC, USA.
*Author for correspondence (larysa_pevny@med.unc.edu)
†These authors contributed equally to this work
Accepted 23 November 2010
SUMMARY
In humans, haploinsufficiency of either SOX2 or PAX6 is associated with microphthalmia, anophthalmia or aniridia. In this study,
through the genetic spatiotemporal specific ablation of SOX2 on both wild-type and Pax6-haploinsufficent backgrounds in the
mouse, we have uncovered a transcriptionally distinct and developmentally transient stage of eye development. We show that
genetic ablation of SOX2 in the optic cup results in complete loss of neural competence and eventual cell fate conversion to non-
neurogenic ciliary epithelium. This cell fate conversion is associated with a striking increase in PAX6, and genetically ablating
SOX2 on a Pax6-haploinsufficient background partially rescues the Sox2-mutant phenotype. Collectively, these results
demonstrate that precise regulation of the ratio of SOX2 to PAX6 is necessary to ensure accurate progenitor cell specification,
and place SOX2 as a decisive factor of neural competence in the retina.
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between prospective NR and CE. One of these potential regulators
of NR specification is the high mobility group (HMG)-containing
transcription factor SOX2. Conditional deletion of Sox2 in the
developing mouse retina results in the loss of competence to
undergo neuronal differentiation, and mice that are hypomorphic
for Sox2 exhibit reduced eye size (Taranova et al., 2006).
Moreover, ~10% of human individuals with anophthalmia (lack of
eye) or severe microphthalmia (small eye) carry a SOX2 mutation
(Fantes et al., 2003; Hagstrom et al., 2005; Hanson and Van
Heyningen, 1995; Ragge et al., 2005a; Ragge et al., 2005b;
Zenteno et al., 2005; Zenteno et al., 2006) (for a review, see Hever
et al., 2006).
Although both SOX2 and PAX6 have been shown to be essential
for the maintenance of multipotent retinal progenitor cells (RPCs)
(Marquardt et al., 2001; Taranova et al., 2006; Xu et al., 1999) and
studies in mouse illustrate that changes in SOX2 and PAX6 dosage
result in developmental defects of the eye, no study has yet
addressed their epistatic relationship in the developing optic cup.
To examine the relationship between Sox2 and Pax6 in the optic
cup, we performed genetic analysis in the mouse and uncovered a
mechanism through which the eyecup is regionalized into NR and
CE. We show that SOX2 and PAX6 are expressed in an inverse
gradient in the developing optic cup and find that ablation of SOX2
in multipotent optic cup progenitor cells biases them towards a
non-neurogenic CE fate. The immediate molecular readout of this
cell fate conversion is the upregulation of PAX6. Accordingly, the
deletion of Sox2 on a Pax6-haploinsufficient background
(Pax6Sey/+) significantly rescues the Sox2-mutant phenotype.
Therefore, in the absence of SOX2, multipotent RPCs cannot
maintain neuronal differentiation capacity (i.e. NR identity) and
undergo cell fate conversion to CE. These results identify SOX2 as
a crucial factor defining multipotent neural retinal progenitor
identity (Taranova et al., 2006) and suggest a model of dosage-
dependent transcriptional regulation of cell fate in the optic cup.
MATERIALS AND METHODS
Mouse breeding
Sox2cond/+ mice (Taranova et al., 2006) were crossbred to aP0CREiresGFP (Dr
P. Gruss, Max-Planck-Institute of Biophysical Chemistry, Germany)
(Marquardt et al., 2001) or Chx10CreGFP (Jackson Laboratories, Bar Harbor,
ME, USA) (Rowan and Cepko, 2004) to generate Sox2cond/+; aP0CREiresGFP
and Sox2cond/+; Chx10CreGFP mouse lines. These lines were then
backcrossed to the Sox2cond line to generate homozygous mutant genotypes.
Lineage tracing was carried out using Rosa26Reporter (R26R) mice
(Jackson Laboratories) (Soriano et al., 1987). Pax6Sey/+ mice (Dr A.
LaMantia, The George Washington University, DC, USA) (Hill et al.,
1991) were bred to Sox2cond/+; aP0CREiresGFP mice to obtain Sox2cond/+;
aP0CREiresGFP; Pax6Sey/+ mice and then backcrossed to Sox2cond/+ mice to
yield the Sox2cond/cond; Pax6Sey/+; aP0CREiresGFPdouble mutant. -
cateninactivated mice (Dr R. Wechsler-Reya, Duke University, Durham, NC,
USA) (Harada et al., 1999) were crossed with the aP0CREiresGFP to obtain
the constitutively activated genotype -cateninactivated; aP0CREiresGFP.
Primer sequences for all of the alleles mentioned can be found in Table S1
in the supplementary material. It was necessary to genotype for the
Sox2Dcond allele to eliminate animals in which germline recombination
occurred. All animal work was carried out in accordance with University
of North Carolina at Chapel Hill IACUC and DLAM approval.
Tissue preparation, immunohistochemistry and in situ
hybridization
Mouse embryos were fixed in 4% paraformaldehyde in phosphate buffered
saline (PBS). Tissue was immersed sequentially in 10%, 20% and 30%
sucrose in DEPC PBS overnight and then embedded and frozen in OCT
(optimal cutting temperature) medium (Tissue-Tek). Horizontal cryostat
sections (14 mm) were blocked in 1% goat serum and 0.1% Triton X-100
in PBS and incubated with primary antibodies at 4°C overnight and
secondary antibodies for one hour at room temperature. The following
antibodies were used in this study: rabbit anti-cleaved caspase 3 (1:300,
Cell Signaling), chicken anti-GFP (1:2000, Abcam), rabbit anti-Ki67
(1:1000, Abcam), mouse anti-PAX6 (1:100, Hybridoma), rabbit anti-SOX2
(1:3000, Millipore), mouse anti--tubulin III (1:1000, Covance), Alexa
Fluor 488-conjugated anti-chicken (1:2000, Molecular Probes),
Alexa Fluor 546-conjugated anti-mouse (1:2000, Molecular Probes) and
Alexa Fluor 546-conjugated anti-rabbit (1:2000, Molecular Probes). In situ
hybridization was performed on cryostat sections (20 mm) using
digoxygenin (DIG)-labeled antisense probes followed by enzymatic
detection according to manufacturer’s protocols (Roche). The following in
situ probes were employed in this study: Axin2 [Dr F. Costantini (Jho et
al., 2002)], Bmp4 [Dr A. LaMantia (Bhasin et al., 2003], Bmp7 [Dr B.
Hogan (Lyons et al., 1995)], Chx10 [Dr R. McInnes (Horsford et al.,
2005)], Hes5 [Dr E. Anton (Chenn and Walsh, 2002)], Lef1 [Dr R.
Grosschedl (Galceran et al., 1999)], Msx1 [Dr Y. Liu (Liu et al., 2006)],
NeuroD1 [Dr J. Lee (Lee et al., 1995)], Notch1 [Dr U. Lendahl (Lardelli
and Lendahl, 1993)], Rax [Dr C. Cepko (Furukawa et al., 1997)], Sfrp2 [Dr
J. Nathans (Rattner et al., 1997)], Otx1 [Dr J. P. Martinez (Simeone et al.,
1992)], Pax6 [Dr A. LaMantia (Anchan et al., 1997)] and Zic1 [Dr K.
Millen (Aruga et al., 1994)]. For -galactosidase (-gal) staining, slides
were washed with PBS and immersed in -gal staining solution [final
concentrations: 5 mM K3Fe(CN)6 (Sigma), 5 mM K4Fe(CN)6.3H2O
(Sigma), 2 mM MgCl2 (Mallinckrodt), 0.02% Igepal CA-630 (Sigma),
0.01% sodium-deoxycholate (Sigma) and X-gal (1:50, Promega)] overnight
at 37°C. Fluorescent and light microscopy images were taken on a Leica
inverted microscope (Leica DMIRB) using a Q-imaging Retiga-4000RV
digital CCD camera (Vashaw Scientific, Raleigh, NC, USA).
BrdU labeling
Pregnant mothers were weighed and injected with 6 ml/g of 15 mg/ml
BrdU (Sigma B5002) in PBS 2 hours before dissection. Embryos were
sectioned and prepared for immunohistochemistry as stated above and
stained overnight with mouse anti-BrdU (1:500, BD Biosciences).
PAX6 immunofluorescence intensity analysis
PAX6 immunofluorescence intensity was measured in tissue sections taken
from the central-most portion of E14.5 eyes. To exclude intensity variations
caused by the appearance of different cell sections (and correspondingly,
different volumes) at the focus of the objective, optical sectioning was
performed to generate the maximum image projection of the resulting
slices. To capture the whole cell volume, initial optical sectioning was
conducted to determine the objective position at which the fluorescence
intensity in the selected region of interest (ROI) would be maximal. The
ROI (at least 20 cells per ROI) was selected at similar locations in each
sample. The maximum intensity plane served as a reference point. For the
final imaging for intensity calculations, a stack of 13 mm (6.5 mm above
and below the reference point) was collected. Twenty cells from each
region of the eyecup (the lens epithelium, prospective CE, retinal ganglion
cells, SOX2-positive neural progenitors and SOX2-ablated neural
progenitors) were selected from the final 8-bit image for fluorescence
intensity calculations and the intensity was plotted using the Olympus
Fluoview 2.1c. All intensity measurements were conducted on an Olympus
Fluoview FV1000 confocal microscope with a 40 NA0.6 objective
(Olympus Corp.). Statistics calculations were performed using Excel
software (Microsoft, Redmond, WA, USA).
RESULTS
The central NR and the peripheral optic cup
margin are defined by an inverse gradient of
SOX2 and PAX6
To establish the functional interaction between SOX2 and PAX6 in
the specification of optic cup progenitor cells, we first compared
their expression patterns using immunohistochemistry. SOX2 and
PAX6 are co-expressed in the anterior neural plate and throughout
the optic vesicle prior to optic cup formation (Rex et al., 1997;











Uchikawa et al., 2003; Uwanogho et al., 1995). However, in the
early optic cup (E10.5), SOX2 and PAX6 began to exhibit inverse
expression gradients. Whereas SOX2 was highly expressed in the
prospective NR (Fig. 1A,B) in a graded centralhigh-to-distallow
pattern, PAX6 was highly expressed in prospective CE and RPE
(Fig. 1A,C) in a gradient from centrallow-to-distalhigh (Baumer et
al., 2002; Grindley et al., 1997; Kamachi et al., 2001; Walther et
al., 1991). These inverse expression patterns were maintained
throughout early optic cup development (Fig. 1D,G,J).
Consequently, in the adult, SOX2 appeared to be excluded from the
non-neural CE and RPE (see Fig. S1A,C in the supplementary
material), whereas PAX6 was maintained in the CE (see Fig.
S1B,C in the supplementary material).
To determine whether the SOX2-PAX6 gradient is concurrent
with the early divergence of cell fate into central prospective NR
and peripheral prospective CE, we examined a repertoire of
established optic cup markers at E13.5, before the NR and CE
become morphologically distinguishable. We found that in the
prospective NR, SOX2 and PAX6 (Fig. 2A,B) were co-expressed
with the NR-specific genes Notch1 (Lardelli and Lendahl, 1993),
Hes5 (Chenn and Walsh, 2002) and NeuroD1 (Neurod1 – Mouse
Genome Informatics) (Lee et al., 1995) (Fig. 2D,E,F) and with
the multipotent optic cup progenitor genes Rax and Chx10 (Fig.
2G,H). By contrast, SOX2 was downregulated in the prospective
CE (Fig. 2A,C, box), where Msx1 (Liu et al., 2006), Otx1
(Simeone et al., 1992), Bmp4 (Zhao et al., 2002) (Fig. 2J,K,L)
and Zic1 (data not shown) (Trimarchi et al., 2009) were
preferentially expressed. PAX6 was highly maintained in the
prospective CE (Fig. 2B,I,box).
Ablation of SOX2 results in neurogenic to non-
neurogenic cell fate conversion
We previously generated mice carrying a conditional floxed allele of
Sox2 (Sox2cond/+) (Taranova et al., 2006). To conditionally ablate
SOX2 from multipotent cells throughout the peripheral optic cup, we
used aP0CREiresGFP transgenic mice, in which CRE expression is
driven by the Pax6 retina-specific enhancer a and minimal promoter
P0 beginning at E10.0 (Kammandel et al., 1999; Marquardt et al.,
2001). This mouse line can be used as a transgenic reporter of a
enhancer-driven Pax6 expression in the optic cup (Baumer et al.,
2002). We previously crossed Sox2cond/+ mice with Sox2cond/+;
aP0CREiresGFP mice and showed that ablation of SOX2 results in
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Fig. 1. The neural retina and optic cup margin are defined by an
inverse gradient of SOX2 and PAX6. (A)Schematic of an E12.5 eye
indicating the boundaries of the mouse neural retina (NR), lens (L),
prospective ciliary body epithelium (CE) and retinal pigment epithelium
(RPE). (B-D)Immunohistochemistry on horizontal sections of wild-type
embryos shows high SOX2 expression (red) in the central optic cup and
high PAX6 expression (green) in the peripheral optic cup margin.
(E-J)As the eye develops, the inverse gradients of SOX2 and PAX6
expression are maintained. Scale bar: 100mm.
Fig. 2. Expression profiles of the central neural retina and
peripheral optic cup margin at E13.5 reflect the inverse
expression patterns of SOX2 and PAX6.
(A-C)Immunohistochemistry for SOX2 (red) and PAX6 (green) on
horizontal sections of wild-type mouse eye illustrates inverse gradients
of expression, with SOX2 highly expressed in the central neural retina
(NR) and PAX6 highly expressed in the peripheral optic cup margin.
(D-F)In situ hybridization (ISH) of NR-specific genes shows that Notch1
(D), Hes5 (E) and NeuroD1 (F) are co-expressed with SOX2 in the central
NR. (G-I)ISH of the optic cup progenitor transcription factors Rax (G),
Chx10 (H) and Pax6 (I) shows expression in both the prospective NR and
CE. (J-L)ISH of Msx1 (J), Otx1 (K) and Bmp4 (L) shows expression in the













severe ocular deformities, including extremely reduced eye size
(Taranova et al., 2006). Here, we determine the fate of Sox2-mutant
optic cup progenitor cells by comparing gene expression,
proliferation and cell death in mutant (Sox2cond/cond; aP0CREiresGFP)
eyes with that of control (Sox2cond/+; aP0CREiresGFP) eyes.
We first examined Sox2 and Pax6 expression at E16.5, when
the prospective NR and CE initially become morphologically
distinguishable. In control eyes, the inverse SOX2-PAX6 gradient
was maintained throughout the optic cup, with PAX6 expression
(Fig. 3B) highest in the distal tips and SOX2 expression (Fig. 3C)
highest in the central optic cup. By contrast, SOX2-ablated cells
(Fig. 3I) throughout the prospective NR exhibited an increase in
aP0CREiresGFP reporter (Fig. 3G), PAX6 protein (Fig. 3H) and
Pax6 mRNA expression (Fig. 3U). To confirm this increase in
PAX6 protein, we quantified PAX6 immunofluorescence intensity
in different regions of the eyecup of control and mutant embryos
(see Fig. S2 in the supplementary material). PAX6 was
significantly upregulated exclusively in CRE-positive, SOX2-
ablated progenitor cells of the central optic cup when compared
with wild-type SOX2-positive central progenitor cells
(P<0.0001).
To determine the identity of these Sox2-mutant cells, we
examined the expression of NR-specific genes. Sox2-mutant cells
failed to express the NR markers Notch1 (Fig. 3D,J) and Hes5 (Fig.
3E,K) and markers of postmitotic neurons, including NeuroD1
(Fig. 3F,L) and -tubulin III (Tubb3 – Mouse Genome Informatics)
(data not shown).
We next examined whether this loss of neural characteristics is
specific to the deletion of Sox2 or is associated with decreased
expression of other optic cup progenitor transcription factors, Rax
and Chx10. In contrast to the upregulation of Pax6 upon SOX2
ablation (Fig. 3H,U) Rax (Fig. 3M,S) and Chx10 (Fig. 3N,T)
remained unchanged between controls and mutants. Given that Rax
and Chx10 are expressed in CE progenitors, we hypothesized that
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Fig. 3. Ablation of SOX2 in peripheral optic cup progenitor cells results in loss of neural characteristics, maintenance of optic cup
progenitor transcription factors and central expansion of the optic cup margin. (A-X)Horizontal sections through the eyes of E16.5 mouse
embryos. (A,G)aP0CREiresGFP reporter expression in control (Sox2cond/+; aP0CREiresGFP) and mutant (Sox2cond/cond; aP0CREiresGFP) eyes as indicated by CRE-
GFP expression (green). aP0CREiresGFP is centrally expanded in mutant embryos (G) compared with controls (A). (B,C,H,I) Immunohistochemistry of
SOX2 and PAX6 indicates upregulation of PAX6 (H) throughout the central eyecup in which SOX2 has been ablated (I) when compared with PAX6
expression (B) in SOX2-positive cells (C) of wild-type controls. (D-F,J-L) In situ hybridization (ISH) of the NR-specific genes Notch1 (N,J), Hes5 (E,K)
and NeuroD1 (F,L) indicates loss of expression of members of the Notch1 signaling pathway, Notch1 (J), Hes5 (K) and NeuroD1 (L), in regions where
SOX2 has been ablated (J-L) when compared with wild-type controls (D-F). (M-O,S-U) ISH of Rax (M,S), Chx10 (N,T) and Pax6 (O,U) shows no
change in expression of Rax (S) or Chx10 (T) but increased expression of Pax6 (U) in SOX2-ablated eyes (S-U) when compared with wild-type
controls (M-O). (P,Q,V,W) ISH shows the expansion of the CE markers Bmp7 (P,V) and Otx1 (Q,W) into the prospective NR of Sox2-mutant eyes.











Sox2-mutant cells might gain CE characteristics, so we examined
the expression of established CE markers. Our data indicate that
some Sox2-mutant cells ectopically express a subset of genes
normally restricted to the prospective CE, including Bmp7 (Fig.
3P,V) and Raldh2 (Aldh1a2 – Mouse Genome Informatics; data not
shown). Otx1 (Fig. 3Q,W), which is normally restricted to the distal
tips of the optic cup, exhibited slight central expansion in Sox2-
mutant eyes. However, most Sox2-mutant cells failed to express
other prospective CE genes, including Msx1 (Fig. 3R,X) and Mitf
(data not shown) at E16.5.
The Wnt/-catenin signaling pathway has been implicated in
the specification of CE fate (Cho and Cepko, 2006; Liu, F. et al.,
2007; Liu et al., 2003). We examined components of this
pathway to test the hypothesis that the Wnt signaling domain is
expanded upon Sox2 deletion. Axin2, an endogenous readout of
Wnt activity (Fuhrmann et al., 2009; Jho et al., 2002), was
increased in Sox2-mutant cells compared with wild-type controls
(see Fig. S3F,M in the supplementary material), but Lef1
expression appeared to be unchanged (see Fig. S3E,L in the
supplementary material). Sfrp2, a Wnt signaling antagonist
expressed in NR progenitors (Liu et al., 2003), was centrally
shifted (see Fig. S3D,K in the supplementary material). Taken
together, these data suggest that the active Wnt signaling domain
is centrally expanded upon SOX2 ablation.
Forced expression of a stabilized form of -catenin in optic cup
progenitors has been used previously to model the role of Wnt
signaling in CE induction (Liu, H. et al., 2007). We therefore
compared expression of prospective NR and CE genes between
Sox2-mutant embryos and embryos with constitutive activation
of Wnt signaling. Consistent with the previous results of Liu et
al. (Liu, H. et al., 2007), regions with stabilized -catenin
(cateninactivated; aP0CREiresGFP) exhibited upregulation of Lef1 and
Axin2 (see Fig. S3S,T in the supplementary material) and failed to
express the NR markers Sox2, Hes5 and Sfrp2 (see Fig. S3O-R in
the supplementary material). However, in contrast to Sox2-mutant
eyes, which exhibited central expansion of CRE and increased
Pax6 expression, regions that constitutively express -catenin did
not show expansion of aP0CREiresGFP and did not express Pax6
(see Fig. S3I,N,P,U in the supplementary material). Thus, the loss
of SOX2 parallels activation of -catenin at E16.5 in the
expansion of the Axin2-positive domain and the loss of NR
characteristics.
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Fig. 4. Ablation of SOX2 by
aP0CREiresGFP results in cell
fate conversion of the
neurogenic retina to non-
neurogenic CE. (A-L) Low
(A-L) and high magnification
(A-L) images of horizontal




mouse pups. Boxes indicate
the magnified regions.
aP0CREiresGFP expression is in
the distal tips as well as in the
inner nuclear layer and retinal
ganglion cell layer of control
eyes (A,A). By contrast,
aP0CREiresGFP expression
expands throughout the
prospective NR of Sox2-
mutant eyes (D,D). -tubulin
III antibody staining (B,B,E,E)
and in situ hybridization (ISH)
for Hes5 (C,C,F,F) are present
only throughout the SOX2-
positive neural retina (NR) of
mutant eyes and not in SOX2-
ablated regions when
compared with controls. ISH of
CE-specific genes, including
Pax6 (G,G,J,J), Msx1
(H,H,K,K) and Zic1 (I,I,L,L),
indicates upregulation in
mutant eyes when compared
with controls. CE, ciliary
epithelium; RPE, retinal
pigment epithelium. Scale
bars: in L, 400mm for A-L; in












Based on the central expansion of some genes known to be
involved in specifying CE fate, we hypothesized that the loss of
SOX2 induces a transient liminal or ‘in-between’ state in which a
maturation period is required for cells to fully adopt CE identity. To
test this hypothesis, we examined the expression of NR- and CE-
specific genes in control and Sox2-mutant eyes at postnatal day (P)
0. In control eyes, the NR exhibited laminar morphology and
aP0CREiresGFP expression in the inner nuclear layer and retinal
ganglion cell layer (Fig. 4A,A). The CE contained a single layer of
cuboidal cells with high aP0CREiresGFP expression (Fig. 4A, box and
4A, arrow). The NR-specific gene Hes5 was expressed throughout
the laminar NR, marking an abrupt boundary between the
neurogenic retina and non-neurogenic CE (Fig. 4C,C). The
neurogenic and non-neurogenic regions were also distinguishable by
the edge of -tubulin III expression (Fig. 4B,B). In stark contrast to
control eyes, Sox2-mutant eyes showed expanded aP0CREiresGFP
expression throughout the central eyecup (Fig. 4D,D). Similar to
what was observed in the eyes of mutant embryos, postnatal Sox2-
mutant cells failed to express genes specific to the NR, including
Hes5 (Fig. 4C,C,F,F), and lost neuronal differentiation capacity as
demonstrated by the mutual exclusivity of -tubulin III and
aP0CREiresGFP expression (Fig. 4B,B,E,E). In addition to the
upregulation of aP0CREiresGFP, Sox2-mutant cells gained expression
of genes that were preferentially expressed in the CE at P0, including
Pax6, Msx1 and Zic1 (Fig. 4G-I). These ectopic CE-like regions
exhibited the thin single-layered morphology characteristic of wild-
type CE. By contrast, the SOX2-positive NR regions, which
presumably developed from cells that did not undergo CRE-
mediated recombination, exhibited proper thickness and laminar
morphology when compared with the NR of control eyes. These
results suggest that Sox2-mutant progenitors autonomously undergo
cell fate conversion from neurogenic retina to non-neurogenic CE.
Previous studies have shown that the development of the CE
monolayer results from a decrease in cell division. Indeed, the optic
cup margin exhibits a lower proliferation rate than does the
prospective NR (Beebe, 1986; Cho and Cepko, 2006; Kubota et al.,
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Fig. 5. Mosaic ablation of SOX2 in neural progenitor cells using Chx10CreGFP results in loss of neuronal differentiation, maintenance of
optic cup progenitor genes and central expansion of the optic cup margin. (A-X)Horizontal sections through the eyes of E14.5 control
(Sox2cond/+; Chx10CreGFP) and mutant (Sox2cond/cond; Chx10CreGFP) mouse embryos. (A-C,G-I) Chx10CreGFP reporter (B,C,H-I; green) double labeled
with SOX2 (A,B,G-H; red) or -tubulin III (C,I,I; red) shows expression throughout the whole optic cup in control eyes. In mutant eyes, CRE-GFP is
mutually exclusive of SOX2 (H) and -tubulin III (I). Arrowheads indicate regions in which SOX2 has been ablated. (D-F,J-X) In situ hybridization (ISH)
of Notch1 (D,J), Hes5 (E,K), NeuroD1 (F,L), Sfrp2 (M,S) and the optic cup progenitor genes Pax6 (N,T), Chx10 (O,U) and Rax (P,V) shows loss of
expression of members of the Notch1 signaling pathway (J-L), central restriction of the Wnt antagonist Sfrp2 (S), upregulation of Pax6 (T) and
maintenance of the progenitor markers Chx10 (U) and Rax (V) in regions where SOX2 has been ablated (G) when compared with wild-type controls
(D-F,M-P). ISH of the CE marker Bmp7 (Q,W,W) shows expansion into the prospective NR of mutant embryos, whereas Msx1 (R,X) shows little











2004). Examination of proliferation markers revealed that many
SOX2-ablated cells, particularly in the peripheral region of the
eyecup, did not incorporate BrdU (see Fig. S4B,F in the
supplementary material) or express Ki67 (see Fig. S4C,G in the
supplementary material). However, many SOX2-ablated cells in
the central eyecup did. These results suggest that upon the deletion
of Sox2 by aP0CREiresGFP, there is decrease in the number of
proliferating cells, particularly throughout the peripheral eyecup.
By contrast, there was no significant change in apoptosis as
indicated by cleaved caspase-3 expression (see Fig. S4D,H in the
supplementary material).
Optic cup progenitor transcription factors PAX6,
CHX10 and RAX are not sufficient to maintain
neuronal differentiation capacity in the absence
of SOX2
The previous data suggest that ablation of SOX2 in multipotent
peripheral progenitor cells that can give rise to both NR and CE
results in their eventual restriction to CE fate. To test further the
hypothesis that cells that are specified to become NR will convert
to CE upon loss of SOX2, we used the Chx10CreGFP mouse line to
ablate SOX2 in a mosaic pattern of progenitor cells throughout the
whole optic cup beginning at E11.0. Thus, SOX2 was removed
from alternating patches of cells that had been specified to become
NR, and neighboring wild-type cells could serve as internal
controls (Fig. 5B,C,H-I) (Donovan and Dyer, 2004; Jadhav et al.,
2006; Oron-Karni et al., 2008; Rowan et al., 2004; Zhang et al.,
2004). In Sox2cond/cond; Chx10CreGFP mutant eyes, SOX2 was
specifically ablated in CRE-expressing cells marked by GFP (Fig.
5B,G-H). As a consequence of SOX2 loss, mutant cells did not
undergo neuronal differentiation, as shown by the mosaic
expression of -tubulin III (Fig. 5C,I,I) and NeuroD1 (Fig. 5F,L)
in a pattern mutually exclusive of Chx10CreGFP expression (Fig. 5I,
arrowhead). Moreover, SOX2-ablated cells failed to express the
NR-specific genes Notch1, Hes5 and Sfrp2 (Fig. 5D,E,J,K,M,S).
To determine if these Sox2-mutant progenitor cells undergo cell
fate conversion to CE, we examined the localization of genes
normally expressed in the prospective CE at E14.5. In regions of
SOX2 ablation, Pax6 was upregulated (Fig. 5N,T) and Chx10 (Fig.
5O,U) and Rax (Fig. 5P,V) were maintained. Moreover, Sox2-
mutant cells expressed some prospective CE markers, including
Bmp7 (Fig. 5Q,W,W), but not others, including Msx1 (Fig. 5R,X).
This expression profile recapitulates that of the early Sox2cond/cond;
aP0CREiresGFP mutant cells described above.
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Fig. 6. At P0 mosaic regions
of SOX2 ablation by
Chx10CreGFP in the central
eyecup indicate cell fate
conversion to CE. (A-L)Low
(A-L) and high magnification
(A-L) images of horizontal
sections through the eyes of P0
control (Sox2cond/+; Chx10CreGFP)
and mutant (Sox2cond/cond;
Chx10CreGFP) mouse pups. Boxes
indicate magnified regions.
Immunohistochemistry for SOX2
(A,A,D,D; red), -tubulin III
(B,B,E,E; red) and GFP (A-E;
green) in control and mutant
eyes shows thinning of the
retinal neuroepithelium to ciliary
epithelial (CE)-like morphology
(D-E) and loss of neuronal
differentiation capacity (E,E) in
mosaic regions of SOX2 ablation
(D,D) throughout the mutant
eyecup (D-E) when compared
with wild-type controls (A-B). In
situ hybridization shows the loss
of expression of the NR marker
Hes5 (F,F), upregulation of Pax6
(J,J), and gain of expression of
the CE markers Msx1 and Zic1
(K-L) in SOX2-ablated regions
(D,D) when compared with
wild-type controls (C,C,G-I).
CE, ciliary epithelium; RPE,
retinal pigment epithelium. Scale













The upregulation of Pax6 and Bmp7 suggests that ablation of
SOX2 by Chx10CreGFP induces a liminal state similar to that
observed in Sox2cond/cond; aP0CREiresGFP mutants. At P0, mosaic
regions of Chx10CreGFP expression/SOX2-ablation were clearly
distinguishable from neighboring Chx10CreGFP-negative/SOX2-
postive regions (Fig. 6A,A,D,D). In mutant eyes, SOX2-ablated
regions lacked expression of the NR gene Hes5 (Fig. 6C,C,F,F)
and the postmitotic neuronal marker -tubulin III (Fig.
6B,B,E,E). Conversely, Sox2-mutant regions upregulated Pax6
(Fig. 6G,G,J,J) and cell-autonomously gained expression of the
CE markers Msx1 and Zic1 (Fig. 6H-I,K-L). These data support
our finding that loss of SOX2 in multipotent progenitor cells results
in a temporary liminal state typifying their maturation to CE. In
addition, at P0, Sox2-mutant regions exhibited thin, single-layered
morphology that starkly contrasts with neighboring control regions,
which exhibited proper NR laminar morphology. Therefore, Sox2-
mutant progenitors fated to become NR lose neuronal
differentiation capacity and undergo cell fate conversion to CE
(Cho and Cepko, 2006; Liu, H. et al., 2007).
Fate mapping of Sox2 mutant cells depicts loss of
neural progenitor capacity in the retina
To establish directly whether ablation of SOX2 results in an
autonomous cell fate change from NR to CE, we genetically fate
mapped Sox2-mutant cells using the aP0CREiresGFP mouse line.
Sox2cond/+; aP0CREiresGFP mice were crossed with mice carrying the
Rosa26R CRE reporter allele (Sox2cond/+; R26R/+), which
expresses -galactosidase (-gal) following CRE-mediated
excision of a translational stop cassette, permanently marking the
progeny of CRE-expressing cells (Soriano et al., 1987). Therefore,
cells that express CRE at the time of analysis can be detected using
GFP fluorescence, whereas all the progeny of CRE-positive cells
express -gal. In control Sox2cond/+; aP0CREiresGFP; R26R/+
embryos, aP0CREiresGFP was initially expressed throughout the
peripheral optic cup (Fig. 7A). By E15.5, it became restricted to the
distal tips (Fig. 7B), maintaining high expression in the CE by
E17.5 (Fig. 7D). However, at E15.5 and E17.5, -gal was detected
throughout both the laminar NR (aP0CREiresGFP-negative) and the
distal CE (Fig. 7C,E), leaving only a portion of central NR cells
unmarked. This -gal expression pattern confirms that
aP0CREiresGFP-expressing progenitor cells can give rise to both NR
and CE. By contrast, as previously shown, Sox2cond/cond;
aP0CREiresGFP; R26R/+ mutant eyes exhibited expanded
aP0CREiresGFP expression into the central optic cup (Fig. 7F,G,I),
and all aP0CREiresGFP-positive cells appeared to express -gal (Fig.
7H,J). By E17.5, these -gal-positive regions exhibited thin
morphology when compared with the SOX2-postive -gal-negative
regions in the same eye (Fig. 7J).
Sox2 and Pax6 genes interact to coordinate eye
development
Based on the increase in PAX6 expression upon SOX2 ablation,
we hypothesized that proper regionalization of the optic cup
depends on a fine balance of SOX2 and PAX6 dosage. To test this
hypothesis directly, we performed genetic epistasis analysis of
SOX2 and PAX6 in the developing optic cup. To modulate PAX6
dosage, we used the Pax6Sey/+ mouse line in which a spontaneous
mutation in the Pax6 gene produces a truncated protein that lacks
a DNA-binding homeodomain and the C-terminal transactivation
domain. This truncated PAX6 is considered to be functionally
inactive and is widely used as a Pax6-null allele (Hill et al., 1991;
Hogan et al., 1986; Osumi et al., 2008). Compared with
Sox2cond/+ or Sox2cond/cond mice, which display normal eye
development (Taranova et al., 2006), Pax6Sey/+ mice exhibit
reduced external eye size, iris hypoplasia and small lens (Hill et
al., 1991).
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Fig. 7. Fate mapping Sox2-mutant progenitor cells using aP0CREiresGFP and R26R. (A,F)aP0CREiresGFP (green) is expressed in peripheral progenitor
cells in control (Sox2cond/+; aP0CREiresGFP; R26R) eyes at E13.5, whereas aP0CREiresGFP reporter expression in mutant (Sox2cond/cond; aP0CREiresGFP; R26R) eyes
is expanded into the central prospective neural retina (NR). (B,D,G,I) As the wild-type eye develops, aP0CREiresGFP reporter expression (green) is further
restricted to the peripheral eyecup at E15.5 (B) and serves as a marker of CE by E17.5 (D). In the mutant eye, aP0CREiresGFP reporter expression remains
an indicator for all recombined cells throughout the NR and prospective ciliary epithelium (CE; G,I). (C,E,H,J) -gal reporter assay on E15.5 and E17.5
eyes indicates that aP0CREiresGFP-positive progenitor cells are capable of giving rise to both prospective NR and CE in control eyes but appear to be











To ablate specifically SOX2 in peripheral progenitors on this
Pax6-haploinsufficient background, we crossed Sox2cond/+;
aP0CREiresGFP mice with Sox2cond/+; Pax6Sey/+mice. We then
compared the resulting Sox2cond/cond; aP0CREiresGFP; Pax6Sey/+ (Sox2
Pax6 double mutant) embryos with Sox2cond/cond; aP0CREireGFP (Sox2
single mutant) embryos and Sox2cond/+; aP0CREiresGFP; Pax6Sey/+
(Pax6 single mutant) control embryos. Sox2 Pax6 double mutant
eyes, which have reduced levels of both SOX2 and PAX6, were
significantly normalized compared with Sox2 single mutant eyes,
which are wild type for Pax6 but lose SOX2 upon CRE-mediated
ablation (Fig. 8J-AA). The central expansion of aP0CREiresGFP seen
in Sox2 single mutant eyes was significantly rescued in Sox2 Pax6
double mutant eyes (Fig. 8J-AA). Lineage tracing analysis using the
Rosa26R CRE reporter showed that the domain of aP0CREiresGFP
activity, as marked by -gal expression, is peripherally restricted in
Sox2 Pax6 double mutants compared with Sox2 single mutants.
These data indicate that aP0CREiresGFP expression in Sox2 Pax6
double mutants is restored to an expression pattern that more closely
resembles that of controls (Fig. 8B,K). Nevertheless, aP0CREiresGFP
expression co-localized with -gal activity in Sox2 Pax6 double
mutants (Fig. 8B,C,K,L), which is consistent with the maintenance
of aP0CREiresGFP in SOX2-ablated cells as described above (Fig. 7).
The ablation of SOX2 in the Pax6-haploinsufficient background
significantly rescued neuronal differentiation capacity, as illustrated
by normalization of -tubulin III (Fig. 8D,M,V), Notch1 (Fig.
8E,N,W), Hes5 (Fig. 8F,O,X) and NeuroD1 (Fig. 8G,P,Y).
Modulating SOX2 or PAX6 levels did not affect Rax (Fig. 8H,Q,Z)
or Chx10 (Fig. 8I,R,AA) expression.
To determine whether this rescue phenotype is maintained
postnatally, we examined Sox2 Pax6 double mutants at P0 and found
a slightly expanded region of aP0CREiresGFP-positive thin CE-like
cells compared with Pax6 single mutant controls (see Fig. S5A-H in
the supplementary material, brackets). This result contrasts with the
single-layered morphology and CE gene expression present
throughout the center of the eyecup in Sox2 single mutants (see Fig.
S5I-L in the supplementary material). Moreover, the NR of Sox2
Pax6 double mutants exhibited proper laminar morphology and
neuronal differentiation capacity as indicated by -tubulin III and
Hes5 expression, and Msx1 expression was restricted to the distal tips
(see Fig. S5F-H in the supplementary material). Therefore, Sox2
Pax6 double mutants more closely resembled Pax6 single mutants
than Sox2 single mutants.
DISCUSSION
SOX2 maintains neuorgenic fate of proliferating
neuorepithelial progenitor cells
Here, we have demonstrated for the first time that the genetic
ablation of SOX2 causes a neurogenic-to-non-neurogenic cell fate
conversion. These results place SOX2 as a crucial factor defining
neurogenic identity in retinal neuroepithelium. In early stage mouse
embryos, SOX2 expression marks the region fated to become neural
ectoderm and its appearance in chicken embryos coincides with the
onset of neural fate specification (Wood and Episkopou, 1999).
Inhibition of SOX2 function in Xenopus embryos blocks neural
differentiation, and SOX2 signaling in chick has been shown to
promote proliferation and inhibit neuronal differentiation (Bylund et
al., 2003; Graham et al., 2003; Kishi et al., 2000). In the retina,
unlike in other regions of the CNS, SOX2 is expressed exclusively
of the highly related SOXB1 factors, SOX1 and SOX3. Thus, the
optic cup, which retains the unique capacity to generate non-
neurogenic structures, provides an excellent model for studying the
transcriptional role of SOX2 in maintaining neurogenic identity.
SOX2 ablation initiates gradual cell fate
conversion from NR to CE
Secreted molecules known to affect neurogenic versus non-
neurogenic optic cup cell fate include FGFs, BMPs and Wnts. A
previous report showed that converging FGF and BMP signals
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Fig. 8. Pax6-haploinsufficiency significantly rescues the Sox2-mutant NR. (A,B,J,K,S,T) Comparison of SOX2 immunohistochemistry (red) with
aP0CREiresGFP expression (green) in Pax6 single mutant (Sox2cond/+; aP0CREiresGFP; Pax6Sey/+), Sox2 Pax6 double mutant (Sox2cond/cond; aP0CREiresGFP; Pax6Sey/+)
and Sox2 single mutant (Sox2cond/cond; aP0CREiresGFP) eyes indicating little to no SOX2 expression in the Sox2 single mutant compared with the other two
genotypes. (C,L,U) -gal activity illustrating the progeny of all aP0CREiresGFP-expressing cells indicates rescue of aP0CREiresGFP expression in Sox2 Pax6
double mutants. (D,M,V) -tubulin III (red) shows maintenance of neuronal differentiation capacity in Pax6 single mutants and Sox2 Pax6 double
mutants but not in Sox2 single mutants. (E-I,N-R,W-AA) In situ hybridization of Notch1 (E,N,W), Hes5 (F,O,X), NeuroD1 (G,P,Y), Rax (H,Q,Z) and Chx10












might define the prospective NR-CE boundary at optic vesicle
stages of the chick (Dias da Silva et al., 2007). BMP signaling
appears to be required for Otx1 and Msx1 expression in the
prospective CE (Zhao et al., 2002), and Msx1 expression has been
shown to be induced by activated Wnt signaling (Willert et al.,
2002). Thus, overlapping FGF, BMP and Wnt signals might
coordinate the cell-intrinsic gene expression necessary for CE
development. However, at least one study has demonstrated
induced ectopic CE marker expression without the onset of Wnt2b
expression (Dias da Silva et al., 2007). Interestingly, it has been
proposed that extrinsic signals that direct neurogenic versus non-
neurogenic fate converge at the regulation of SOX proteins (Wilson
et al., 2001). Here, we have investigated the cell-intrinsic role of
SOX2 and PAX6 in setting up the NR-CE boundary in the optic
cup.
Using genetic fate mapping, we have demonstrated that removal
of a transcription factor, SOX2, converts prospective NR to CE.
Our results are consistent with previous data showing that neural
RPCs maintain multipotent differentiation capacity (i.e. the
capacity to form CE) at a developmental time point (E11.0)
subsequent to the division of NR and CE fate (Fekete et al., 1994;
Turner and Cepko, 1987; Turner et al., 1990). The gradual cell fate
conversion upon Sox2 deletion is characterized by: (1) loss of the
NR markers Notch1, Hes5, NeuroD1 and Sfrp2 (see Table 1, neural
retina markers); (2) maintenance of the multipotent progenitor
genes Chx10, Rax and Pax6 (see Table 1, optic cup progenitor
transcription factors); (3) expansion of Wnt and BMP signals; and
(4) decreased proliferation with progressive thinning of the
neuroepithelium. These characteristics define a liminal or in-
between state that culminates in the expression of CE markers,
including Otx1, Zic1 and Msx1 (see Table 1, ciliary epithelium
markers). A similar delay in the consolidation of CE identity in
response to ectopic Wnt signaling has been previously
demonstrated (Cho and Cepko, 2006). In both instances, the delay
could be due to the presence of competing signals in the eyecup:
Wnt signals promote non-neurogenic fate but multipotent
progenitor genes and Wnt antagonists promote neurogenic fate.
Intriguingly, activation of -catenin in the eyecup was shown to
produce a stronger and more rapid onset of CE characteristics than
did Wnt2b overexpression, suggesting that stabilized -catenin
bypasses Wnt antagonists in the prospective NR to cause a more
immediate increase in CE gene expression (Cho and Cepko, 2006).
Thus, the presence of Wnt antagonists might explain why
consolidation of CE fate is gradual upon SOX2 ablation but rapid
upon -catenin activation (Liu, F. et al., 2007).
Sox2 and Pax6 interact to regionalize the optic
cup
A major difference between SOX2 loss-of-function and -catenin
gain-of-function in the prospective retina is the effect on Pax6.
Ablation of SOX2 leads to an immediate increase in Pax6
expression, whereas activation of -catenin diminishes Pax6
expression. In humans, haploinsufficiency of PAX6 is associated
with anterior eye formations, including defects of the iris and
ciliary body (for reviews, see Hever et al., 2006; Hill et al., 1991).
In the mouse, deletion of one copy of Pax6 in the distal optic cup
resulted in the loss of CE precursors and a distal shift in the
boundary between prospective NR and CE (Davis-Silberman et al.,
2005). Moreover, transgenic overexpression of Pax6 resulted in
abnormalities of the ciliary body, the iris and the cornea (Schedl et
al., 1996). These studies demonstrate the importance of regulating
appropriate levels of PAX6 for the proper development of
peripheral eye structures. Here, we have described increased Pax6
expression in the optic cup upon the removal of a potential
repressor.
Our genetic epistasis analyses provide evidence for a mechanism
of PAX6 regulation in the developing eyecup. The dramatic
increase in PAX6 upon Sox2 deletion and the subsequent NR-to-
CE cell fate conversion suggest that SOX2 normally antagonizes
PAX6 signaling to maintain NR identity. Moreover, the genetic
rescue of eye development by lowering PAX6 levels while deleting
Sox2 indicates a functional antagonism between the two genes.
These data raise the possibility that neurogenic versus non-
neurogenic fate in the optic cup is extremely sensitive to the ratio
of PAX6 to SOX2.
We propose a model (see Fig. S6 in the supplementary material)
in which SOX2 levels are high enough to antagonize Pax6
expression in central optic cup progenitor cells, thereby
maintaining neurogenic capacity. Conversely, in the peripheral
optic cup, SOX2 levels are low, perhaps allowing PAX6 to activate
its own expression via the a enhancer. In fact, previous studies
have shown that PAX6 can directly bind a conserved site in a, and
that lowering PAX6 levels decreases a-driven CRE-GFP
expression (Baumer et al., 2002; Schwarz et al., 2000). Further
studies are needed to address the question of whether SOX2 and
PAX6 coordinate Pax6 expression through the a enhancer. Indeed,
SOX2 and PAX6 have been shown to co-regulate expression of the
-crystallin gene in the lens, where they form a complex at the
DC5 enhancer that is stabilized by both protein-protein and protein-
DNA interactions (Kamachi et al., 2001). A similar co-regulation
of a enhancer activity might control Pax6 expression in the optic
cup given that the a enhancer has been suggested to mediate the
proximallow-to-distalhigh PAX6 gradient (Baumer et al., 2002;
Davis-Silberman et al., 2005).
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Table 1. Expression profiles of the prospective neural retina
(NR) and ciliary body epithelium (CE)
E13.5 wild type P0 wild type
Marker NR OCM NR CE
Neural retina
Sox2 + – + –
Sfrp-2 + – + –
Notch1 + – + –
Hes5 + – + –
NeuroD1 + – + –
Math5 + – + –
OCPTF
Chx10 + + + –
Six3 + + + –
Rax + + + –
Pax6 + + + +
Ciliary epithelium
Axin2 – + – +
Bmp7 – + – +
Lef1 – + – +
Raldh2 – + – +
Otx1 – + – +
Msx1 – + – +
Mitf – + – +
Zic1 – + – +
At E13.5 and P0, NR markers are present throughout the central eyecup. The optic
cup progenitor transcription factors are present in both the prospective NR and CE
(OCM) at E13.5 but lose expression in the CE by P0. CE markers are restricted to the
peripheral eyecup at both stages.











Although the role of secreted signaling molecules in positioning
the boundary between prospective NR and CE has been studied
extensively, little is known about the cell-intrinsic mechanisms
responsible for setting up or maintaining this boundary. Our results
suggest a tightly coordinated dosage-dependent transcriptional
mechanism directing NR versus CE cell fate. We have shown that
the functional antagonism between SOX2 and PAX6 is necessary
for proper patterning of the eyecup, such that in the absence of
SOX2, PAX6 is not sufficient to maintain NR identity, and cells
originally fated to become retinal neurons instead take on a
peripheral non-neurogenic cell fate.
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